ING Groep NV lowered its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 40.6% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 27,864 shares of the company's stock after selling 19,080 shares during the quarter. ING Groep NV's holdings in HCA Healthcare were worth $9,628,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Allianz SE increased its stake in HCA Healthcare by 59.4% during the first quarter. Allianz SE now owns 5,389 shares of the company's stock worth $1,862,000 after purchasing an additional 2,009 shares during the period. Raiffeisen Bank International AG increased its stake in shares of HCA Healthcare by 67.3% during the first quarter. Raiffeisen Bank International AG now owns 6,646 shares of the company's stock worth $2,274,000 after buying an additional 2,674 shares during the period. Heritage Trust Co increased its stake in shares of HCA Healthcare by 1.6% during the first quarter. Heritage Trust Co now owns 8,373 shares of the company's stock worth $2,893,000 after buying an additional 133 shares during the period. Argent Trust Co increased its stake in shares of HCA Healthcare by 11.3% during the first quarter. Argent Trust Co now owns 6,071 shares of the company's stock worth $2,098,000 after buying an additional 615 shares during the period. Finally, Manchester Capital Management LLC increased its stake in shares of HCA Healthcare by 111.3% during the first quarter. Manchester Capital Management LLC now owns 243 shares of the company's stock worth $84,000 after buying an additional 128 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.
HCA Healthcare Price Performance
HCA stock traded up $2.27 during trading on Wednesday, hitting $366.08. The stock had a trading volume of 1,125,177 shares, compared to its average volume of 1,614,266. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. The stock has a market cap of $85.66 billion, a price-to-earnings ratio of 15.39, a price-to-earnings-growth ratio of 1.14 and a beta of 1.39. The company's 50 day moving average price is $370.09 and its two-hundred day moving average price is $348.16. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14.
HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The business had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. The company's revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.50 EPS. On average, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.
HCA Healthcare Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.8%. HCA Healthcare's dividend payout ratio is presently 12.11%.
Analysts Set New Price Targets
HCA has been the topic of several recent analyst reports. JPMorgan Chase & Co. increased their price target on shares of HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a research note on Monday. Barclays dropped their price target on shares of HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating on the stock in a research note on Monday, July 28th. Wall Street Zen upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Wolfe Research lowered shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research report on Monday, July 28th. Finally, Royal Bank Of Canada decreased their price target on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a report on Monday, July 28th. Nine research analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $395.69.
Get Our Latest Stock Report on HCA Healthcare
Insider Activity
In related news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the transaction, the chief operating officer owned 12,646 shares of the company's stock, valued at $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 1.30% of the company's stock.
HCA Healthcare Company Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Articles

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.